[HTML][HTML] Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …
[HTML][HTML] Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Responsible for more than 4.9 million deaths so far, COVID-19, caused by SARS-CoV-2, is
instigating devastating effects on the global health care system whose impacts could be …
instigating devastating effects on the global health care system whose impacts could be …
[HTML][HTML] An early warning system for emerging SARS-CoV-2 variants
An early warning system for emerging SARS-CoV-2 variants | Nature Medicine Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …
content Thank you for visiting nature.com. You are using a browser version with limited support …
[HTML][HTML] Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
A Keppler-Hafkemeyer, C Greil, PR Wratil… - Nature Cancer, 2023 - nature.com
Individuals with hematologic malignancies are at increased risk for severe coronavirus
disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity …
disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity …
[HTML][HTML] Understanding mutations in human SARS-CoV-2 spike glycoprotein: a systematic review & meta-analysis
Genetic variant (s) of concern (VoC) of SARS-CoV-2 have been emerging worldwide due to
mutations in the gene encoding spike glycoprotein. We performed comprehensive analyses …
mutations in the gene encoding spike glycoprotein. We performed comprehensive analyses …
[HTML][HTML] Spike protein of SARS-CoV-2 variants: a brief review and practical implications
KL Candido, CR Eich, LO de Fariña… - Brazilian Journal of …, 2022 - Springer
The scientific community has been alarmed by the possible immunological evasion, higher
infectivity, and severity of disease caused by the newest variants of SARS-CoV-2. The spike …
infectivity, and severity of disease caused by the newest variants of SARS-CoV-2. The spike …
[HTML][HTML] Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals
M Jaago, A Rähni, N Pupina, A Pihlak, H Sadam… - Scientific Reports, 2022 - nature.com
Immunity to previously encountered viruses can alter response to unrelated pathogens. We
reasoned that similar mechanism may also involve SARS-CoV-2 and thereby affect the …
reasoned that similar mechanism may also involve SARS-CoV-2 and thereby affect the …
Multi-omics for COVID-19: driving development of therapeutics and vaccines
M Guo, M Xiong, J Peng, T Guan, H Su… - National Science …, 2023 - academic.oup.com
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has raised global concern for
public health and economy. The development of therapeutics and vaccines to combat this …
public health and economy. The development of therapeutics and vaccines to combat this …
A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
Exposure to severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) prompts
humoral immune responses in the human body. As the auxiliary diagnosis of a current …
humoral immune responses in the human body. As the auxiliary diagnosis of a current …
[HTML][HTML] Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins
SARS-CoV-2 infection or vaccination produces neutralizing antibody responses that
contribute to better clinical outcomes. The receptor-binding domain (RBD) and the N …
contribute to better clinical outcomes. The receptor-binding domain (RBD) and the N …